Prime Medicine, Inc. Profile Avatar - Palmy Investing

Prime Medicine, Inc.

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase…

Biotechnology
US, Cambridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PRME's Analysis
CIK: 1894562 CUSIP: 74168J101 ISIN: US74168J1016 LEI: - UEI: -
Secondary Listings
PRME has no secondary listings inside our databases.